These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19167055)

  • 1. Trade agreements and health in developing countries.
    Stiglitz JE
    Lancet; 2009 Jan; 373(9661):363-5. PubMed ID: 19167055
    [No Abstract]   [Full Text] [Related]  

  • 2. Trade deal to curb generic-drug use.
    Maxmen A
    Nature; 2012 Sep; 489(7414):16-7. PubMed ID: 22962700
    [No Abstract]   [Full Text] [Related]  

  • 3. [Free trade agreements make the drugs more expensive].
    Jeppsson A
    Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499
    [No Abstract]   [Full Text] [Related]  

  • 4. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 5. US trade rep is pressing Indian government to forbid production of generic cancer drug, consortium says.
    Cohen D
    BMJ; 2014 Nov; 349():g6593. PubMed ID: 25370846
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generic drug lines: all is not gold that glitters].
    Córdoba García R
    Aten Primaria; 1999 Oct; 24(7):387-9. PubMed ID: 10592545
    [No Abstract]   [Full Text] [Related]  

  • 7. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 9. Trade systems in less-developed countries.
    Kamal Smith M; 't Hoen E
    Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324
    [No Abstract]   [Full Text] [Related]  

  • 10. Australian drugs scheme threatens free-trade talks.
    Fickling D
    Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753208
    [No Abstract]   [Full Text] [Related]  

  • 11. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV
    Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 13. World Trade Organization wrestles with access to cheap drugs solution.
    Loff B
    Lancet; 2002 Nov; 360(9346):1670. PubMed ID: 12457799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reference prices].
    Rey Abella ME
    Aten Primaria; 1999 Sep; 24(5):252-4. PubMed ID: 10590555
    [No Abstract]   [Full Text] [Related]  

  • 15. Accord could make Canadian generics industry a 'rust bucket'.
    Hoag H
    Nat Med; 2012 Jul; 18(7):991. PubMed ID: 22772530
    [No Abstract]   [Full Text] [Related]  

  • 16. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
    Sturm AC
    Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: cost savings.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
    [No Abstract]   [Full Text] [Related]  

  • 18. The Problem of Limited-Supply Agreements for Medicare Price Negotiation.
    Gabriele SME; Feldman WB
    JAMA; 2023 Oct; 330(13):1223-1224. PubMed ID: 37713185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 20. Long way down--pharmaceutical companies fear falling off 'patent cliff'.
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.